CVS Health Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Quarter	Current	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun '26 Jun 18, 2026	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Sep '24 Sep 30, 2024	Jun '24 Jun 30, 2024	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023	Jun '23 Jun 30, 2023	Mar '23 Mar 31, 2023	Dec '22 Dec 31, 2022	Sep '22 Sep 30, 2022	Jun '22 Jun 30, 2022	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Sep '21 Sep 30, 2021
Market Cap	125,449	91,427	100,867	95,745	87,398	85,501	56,561	79,103	74,179	99,860	101,700	89,858	88,625	95,043	121,147	125,412	121,570	132,180	136,378	112,100
Market Cap Growth	43.54%	6.93%	78.33%	21.04%	17.82%	-14.38%	-44.38%	-11.97%	-16.30%	5.07%	-16.05%	-28.35%	-27.10%	-28.10%	-11.17%	11.88%	10.54%	33.82%	52.42%	46.64%
Enterprise Value	191,992	158,151	170,387	166,447	156,121	154,241	128,658	152,289	141,920	168,745	169,805	153,939	154,150	153,998	175,767	176,823	181,071	197,063	200,158	178,227
Last Close Price	98.32	71.82	79.36	75.39	68.98	67.75	44.89	62.88	59.06	79.76	78.96	69.82	69.13	74.31	93.19	95.37	92.66	101.21	103.16	84.86
PE Ratio	42.83	31.64	57.09	198.40	19.27	16.17	12.27	15.96	10.51	14.02	12.20	10.50	29.93	23.82	28.59	38.93	14.85	16.73	17.14	14.81
Forward PE	12.89	10.03	11.54	11.39	11.24	11.48	7.77	9.21	8.06	9.61	9.39	8.12	8.04	8.42	10.67	11.01	11.03	12.22	12.88	11.11
PEG Ratio	1.08	0.89	0.76	0.66	0.75	0.49	0.61	2.47	2.01	1.83	1.92	1.58	1.37	1.18	2.05	1.71	1.88	1.89	2.15	1.66
PS Ratio	0.31	0.22	0.25	0.24	0.23	0.23	0.15	0.21	0.20	0.28	0.28	0.26	0.26	0.29	0.38	0.40	0.39	0.44	0.47	0.39
PB Ratio	1.62	1.18	1.34	1.31	1.13	1.11	0.75	1.06	0.99	1.35	1.33	1.21	1.22	1.33	1.70	1.77	1.62	1.79	1.82	1.51
P/FCF Ratio	16.97	12.37	12.92	15.21	18.28	14.39	8.94	46.89	14.07	12.27	9.78	7.95	5.01	5.46	9.01	6.43	7.66	8.16	8.66	7.38
P/OCF Ratio	12.14	8.85	9.48	10.51	11.55	9.76	6.21	17.16	9.19	9.17	7.57	6.37	4.32	4.74	7.49	5.67	6.56	6.98	7.47	6.29
EV/Sales Ratio	0.47	0.39	0.42	0.42	0.40	0.41	0.35	0.41	0.39	0.47	0.47	0.44	0.45	0.47	0.55	0.56	0.59	0.66	0.69	0.63
EV/EBITDA Ratio	12.46	19.22	18.39	17.48	13.87	12.94	9.81	10.80	8.99	9.88	9.38	8.41	16.11	15.56	14.43	22.99	12.34	13.75	11.25	11.31
EV/EBIT Ratio	17.70	26.51	36.56	33.86	17.43	16.04	15.11	16.00	11.46	13.43	12.36	10.97	24.01	19.61	22.10	26.63	13.29	14.84	15.04	13.21
EV/FCF Ratio	25.97	21.39	21.82	26.45	32.66	25.96	20.34	90.27	26.91	20.73	16.34	13.62	8.72	8.85	13.07	9.07	11.41	12.17	12.71	11.73
Debt / Equity Ratio	0.95	0.95	0.98	1.04	0.96	0.97	1.02	1.01	1.04	1.03	0.98	1.02	1.08	1.02	0.96	0.96	0.90	0.94	0.93	1.01
Debt / EBITDA Ratio	9.52	13.52	24.53	-	34.74	17.94	23.59	99.40	27.53	23.99	17.61	16.63	18.93	17.20	14.90	-	15.89	16.52	32.40	25.70
Debt / FCF Ratio	10.60	23.04	30.68	834.20	64.13	21.30	75.93	-	34.20	19.48	-	36.89	15.45	11.85	-	8.32	14.73	30.22	22.30	16.01
Net Debt / Equity Ratio	0.86	0.86	0.92	0.97	0.89	0.89	0.95	0.97	0.90	0.93	0.89	0.86	0.90	0.82	0.76	0.72	0.79	0.88	0.85	0.89
Net Debt / EBITDA Ratio	8.09	11.48	21.28	-21.99	28.79	15.14	20.46	87.77	22.19	20.15	15.07	13.27	15.04	13.21	11.55	-13.03	12.68	14.06	27.06	21.50
Net Debt / FCF Ratio	9.00	19.57	26.61	719.59	53.14	17.98	65.87	-51.61	27.56	16.37	-19.15	29.44	12.27	9.10	-20.58	5.98	11.75	25.71	18.63	13.40
Asset Turnover	0.39	0.39	0.42	0.41	0.39	0.37	0.39	0.38	0.36	0.36	0.39	0.37	0.37	0.36	0.36	0.35	0.35	0.33	0.33	0.32
Inventory Turnover	18.98	4.82	4.93	4.87	5.09	4.75	4.69	4.66	4.67	4.38	4.31	4.23	4.35	3.95	3.80	3.82	3.89	3.55	3.47	3.50
Quick Ratio	0.61	0.61	0.57	0.59	0.58	0.59	0.56	0.54	0.60	0.54	0.59	0.60	0.59	0.61	0.62	0.64	0.62	0.54	0.55	0.59
Current Ratio	0.87	0.87	0.84	0.83	0.80	0.82	0.81	0.80	0.86	0.81	0.86	0.86	0.86	0.92	0.95	0.94	0.91	0.88	0.88	0.94
Return on Equity (ROE)	3.82%	3.82%	3.87%	-5.38%	1.33%	2.36%	2.13%	0.09%	2.39%	1.54%	2.76%	3.11%	2.58%	2.94%	3.17%	-4.67%	4.08%	3.24%	1.91%	2.21%
Return on Assets (ROA)	1.38%	1.38%	1.80%	-1.45%	0.57%	0.91%	0.72%	0.22%	0.92%	0.66%	1.07%	1.15%	1.00%	1.09%	1.17%	-1.29%	1.49%	1.20%	0.83%	0.97%
Return on Invested Capital (ROIC)	1.87%	1.87%	2.41%	-1.93%	0.76%	1.20%	0.95%	0.29%	1.20%	0.86%	1.43%	1.52%	1.30%	1.41%	1.53%	-1.69%	1.91%	1.51%	1.04%	1.23%
Return on Capital Employed (ROCE)	2.81%	2.81%	1.27%	-1.94%	1.42%	2.03%	1.40%	0.49%	1.78%	1.37%	2.05%	2.25%	1.94%	2.11%	2.26%	-2.38%	2.80%	2.13%	1.41%	1.80%
Earnings Yield	2.34%	3.16%	1.75%	0.50%	5.19%	6.18%	8.15%	6.27%	9.52%	7.13%	8.19%	9.52%	3.34%	4.20%	3.50%	2.57%	6.73%	5.98%	5.84%	6.75%
FCF Yield	5.89%	8.09%	7.74%	6.57%	5.47%	6.95%	11.18%	2.13%	7.11%	8.15%	10.22%	12.58%	19.94%	18.30%	11.10%	15.55%	13.05%	12.25%	11.55%	13.55%
Dividend Yield	2.71%	0.93%	0.84%	0.88%	0.99%	0.98%	1.48%	1.06%	1.16%	0.84%	0.77%	0.87%	0.90%	0.82%	0.59%	0.58%	0.61%	0.54%	0.48%	0.59%
Payout Ratio	115.88%	28.78%	28.71%	-21.28%	84.82%	47.22%	50.97%	962.07%	48.47%	75.47%	38.07%	34.45%	41.82%	36.47%	30.81%	-21.32%	24.43%	30.67%	47.24%	41.24%
Buyback Yield / Dilution	-1.07%	-1.19%	-1.27%	-0.79%	-0.87%	0.24%	2.47%	2.40%	2.18%	1.86%	1.97%	1.90%	2.57%	2.79%	1.27%	1.05%	0.45%	-0.45%	-1.44%	-1.06%
Total Shareholder Return	1.64%	-0.26%	-0.43%	0.09%	0.12%	1.22%	3.96%	3.46%	3.33%	2.69%	2.74%	2.77%	3.47%	3.60%	1.86%	1.63%	1.06%	0.09%	-0.96%	-0.48%

SEC Filings: 10-K · 10-Q